z-logo
open-access-imgOpen Access
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report
Author(s) -
Surena F. Matin,
Phillip M. Pierorazio,
Nir Kleinmann,
John L. Gore,
Ahmad Shabsigh,
Brian Hu,
Karim Chamie,
Guilherme Godoy,
Scott G. Hubosky,
Marcelino Rivera,
Michael A. O’Donnell,
Marcus Quek,
Jay D. Raman,
John J. Knoedler,
Douglas Scherr,
Christopher J. Weight,
Alon Z. Weizer,
Michael P. Woods,
Hristos Z. Kaimakliotis,
Angela Smith,
Jennifer Linehan,
Jonathan Coleman,
Mitchell R. Humphreys,
Raymond Pak,
David A. Lifshitz,
Michael Verni,
Itzik Klein,
Marina Konorty,
Dalit Strauss-Ayali,
Gil Hakim,
Elyse Seltzer,
Mark Schoenberg,
Seth P. Lerner
Publication year - 2022
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000002350
Subject(s) - medicine , urothelial carcinoma , mitomycin c , metastatic urothelial carcinoma , urology , surgery , cancer , bladder cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here